KG
INDV icon

Kilter Group’s Indivior Pharmaceuticals INDV Stock Holding History

Kilter Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46K Hold
60
– – ﹤0.01% 938
2026
Q1 		$1.83K Hold
60
– – ﹤0.01% 985
2025
Q4 		$2.15K Sell
60
-9
-13% -$275 ﹤0.01% 753
2025
Q3 		$1.66K Buy
69
+9
+15% +$188 ﹤0.01% 714
2025
Q2 		$885 Buy
+60
New +$699 ﹤0.01% 854

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kilter Group's INDV Position: Q2 2026 in Review

Kilter Group held its Indivior Pharmaceuticals (INDV) position steady in Q2 2026 at 60 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Kilter Group first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Kilter Group held 60 shares of Indivior Pharmaceuticals worth $2.46K as of Q2 2026.
  • Kilter Group left its Indivior Pharmaceuticals share count unchanged in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #938 holding.
  • Kilter Group first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.